Literature DB >> 34324276

Pulmonary hypertension in the child with bronchopulmonary dysplasia.

Kelsey W Malloy1, Eric D Austin1.   

Abstract

Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease of prematurity resulting from complex interactions of perinatal factors that often lead to prolonged respiratory support and increased pulmonary morbidity. There is also growing appreciation for the dysmorphic pulmonary bed characterized by vascular growth arrest and remodeling, resulting in pulmonary vascular disease and its most severe form, pulmonary hypertension (PH) in children with BPD. In this review, we comprehensively discuss the pathophysiology of PH in children with BPD, evaluate the current recommendations for screening and diagnosis of PH, discern associated comorbid conditions, and outline the current treatment options.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  chronic lung disease; premature; pulmonary vascular disease; sildenafil; vasodilator

Mesh:

Year:  2021        PMID: 34324276      PMCID: PMC8530892          DOI: 10.1002/ppul.25602

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  79 in total

1.  Risk Assessment and Monitoring of Chronic Pulmonary Hypertension in Premature Infants.

Authors:  Philip T Levy; Amish Jain; Hythem Nawaytou; David Teitel; Roberta Keller; Jeffery Fineman; Robin Steinhorn; Steven H Abman; Patrick J McNamara
Journal:  J Pediatr       Date:  2019-11-14       Impact factor: 4.406

Review 2.  Respiratory Phenotypes for Preterm Infants, Children, and Adults: Bronchopulmonary Dysplasia and More.

Authors:  Joseph M Collaco; Sharon A McGrath-Morrow
Journal:  Ann Am Thorac Soc       Date:  2018-05

3.  N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants.

Authors:  Leon Joseph; Amiram Nir; Cathy Hammerman; Shmuel Goldberg; Efrat Ben Shalom; Elie Picard
Journal:  Am J Perinatol       Date:  2009-12-11       Impact factor: 1.862

4.  Oxygen-induced alterations in lung vascular development in the newborn rat.

Authors:  R J Roberts; K M Weesner; J R Bucher
Journal:  Pediatr Res       Date:  1983-05       Impact factor: 3.756

5.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.

Authors:  Barbara J Stoll; Nellie I Hansen; Edward F Bell; Michele C Walsh; Waldemar A Carlo; Seetha Shankaran; Abbot R Laptook; Pablo J Sánchez; Krisa P Van Meurs; Myra Wyckoff; Abhik Das; Ellen C Hale; M Bethany Ball; Nancy S Newman; Kurt Schibler; Brenda B Poindexter; Kathleen A Kennedy; C Michael Cotten; Kristi L Watterberg; Carl T D'Angio; Sara B DeMauro; William E Truog; Uday Devaskar; Rosemary D Higgins
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

6.  BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?

Authors:  Robert A Lewis; Charlotte Durrington; Robin Condliffe; David G Kiely
Journal:  Eur Respir Rev       Date:  2020-05-15

7.  B-type natriuretic peptide and mortality in extremely low birth weight infants with pulmonary hypertension: a retrospective cohort analysis.

Authors:  Alain Cuna; Jegen Kandasamy; Brian Sims
Journal:  BMC Pediatr       Date:  2014-03-11       Impact factor: 2.125

8.  Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age.

Authors:  Eui Kyung Choi; Seung Han Shin; Ee-Kyung Kim; Han-Suk Kim
Journal:  BMC Pediatr       Date:  2019-01-17       Impact factor: 2.125

9.  2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT.

Authors:  Georg Hansmann; Martin Koestenberger; Tero-Pekka Alastalo; Christian Apitz; Eric D Austin; Damien Bonnet; Werner Budts; Michele D'Alto; Michael A Gatzoulis; Babar S Hasan; Rainer Kozlik-Feldmann; R Krishna Kumar; Astrid E Lammers; Heiner Latus; Ina Michel-Behnke; Oliver Miera; Nicholas W Morrell; Guido Pieles; Daniel Quandt; Hannes Sallmon; Dietmar Schranz; Karin Tran-Lundmark; Robert M R Tulloh; Gregor Warnecke; Håkan Wåhlander; Sven C Weber; Peter Zartner
Journal:  J Heart Lung Transplant       Date:  2019-06-21       Impact factor: 10.247

10.  Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia.

Authors:  J Check; N Gotteiner; X Liu; E Su; N Porta; R Steinhorn; K K Mestan
Journal:  J Perinatol       Date:  2013-01-17       Impact factor: 2.521

View more
  1 in total

Review 1.  Prematurity and Pulmonary Vein Stenosis: The Role of Parenchymal Lung Disease and Pulmonary Vascular Disease.

Authors:  Shilpa Vyas-Read; Nidhy P Varghese; Divya Suthar; Carl Backes; Satyan Lakshminrusimha; Christopher J Petit; Philip T Levy
Journal:  Children (Basel)       Date:  2022-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.